Latest filing published 07 Jul 2026 for Rezolute, Inc., €13k. Read the official filing
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
This profile gathers the share dealings of Daron Evans across 2 companies, led by Rezolute, Inc. and Nephros Inc. The record holds 20 filings, for trades running from 24 May 2021 to 2 July 2026.
Purchases make up the whole of the open-market record (13 purchases, €577k). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 7 share grants. So far in 2026, the count stands at 1 purchase and no sales.
In size, the median ticket on the buying side is €39k. On 7 out of 13 purchases, another insider of the same company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster.
The newest entry dates from 7 July 2026: a share grant of €13k, in Rezolute, Inc. The last purchase on record was published on 31 March 2026, which is 201 days ago. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
20 of 20 declarations